Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
446.54
+3.38 (+0.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
72
73
Next >
January Has Been 1 of the Worst Months for the S&P 500 Over the Last 20 Years. Here Are 3 Stocks to Buy Anyway.
↗
January 03, 2024
These stocks are smart picks to buy now, regardless of whether the S&P 500 stocks start off 2024 poorly.
Via
The Motley Fool
Topics
Stocks
3 Biotech Stocks Set for Breakthroughs in 2024
↗
January 02, 2024
With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks.
Via
InvestorPlace
2 gene-editing stocks reshaping hereditary disease treatments
January 02, 2024
Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal
Via
MarketBeat
Prediction: These 3 Stocks Will Soar in 2024
↗
January 01, 2024
Investors could enjoy an especially happy new year with these great stocks.
Via
The Motley Fool
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024
↗
December 31, 2023
Ark Invest holds a hefty position in this gene-editing stock. Risk-tolerant investors may want to take a page from the fund's playbook on this name.
Via
The Motley Fool
Decoding Vertex Pharmaceuticals's Options Activity: What's the Big Picture?
↗
December 27, 2023
Via
Benzinga
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
↗
December 27, 2023
With a new medicine on the market and plenty of money, Vertex is in great shape.
Via
The Motley Fool
Market Whales and Their Recent Bets on VRTX Options
↗
December 22, 2023
Via
Benzinga
Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade.
↗
December 30, 2023
These stocks offer attractive risk-reward profiles.
Via
The Motley Fool
2 Exceptional Growth Stocks Up 42% and 66% to Buy Right Now
↗
December 29, 2023
It's been a crazy year across sectors, but winners remain.
Via
The Motley Fool
CRISPR Therapeutics sets sights on gene-editing cures for disease
December 27, 2023
On Dec. 8, 2023, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) announced the U.S. FDA approved its sickle-cell disease (SCD) treatment, Casgevy, for
Via
MarketBeat
3 Monster Stocks to Buy Without Any Hesitation
↗
December 27, 2023
These are easy choices for investors seeking market-beating long-term gains.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 25, 2023
Via
Benzinga
How Is The Market Feeling About Vertex Pharmaceuticals?
↗
December 21, 2023
Via
Benzinga
$1000 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
↗
December 19, 2023
Via
Benzinga
3 Top Stocks to Buy Hand Over Fist Before the End of 2023
↗
December 25, 2023
These are ideal stocks to buy sooner rather than later.
Via
The Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
↗
December 23, 2023
Editas isn't out of the woods yet, but it's better off than before.
Via
The Motley Fool
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
↗
December 23, 2023
The stock has been in the news lately.
Via
The Motley Fool
5 Top Stocks to Buy With Your End-of-the-Year Bonus
↗
December 23, 2023
Your bonus could become the gift that keeps on giving.
Via
The Motley Fool
Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?
↗
December 22, 2023
Both develop medicines for rare diseases, and each aims to conquer a niche market.
Via
The Motley Fool
Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?
↗
December 22, 2023
The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.
Via
The Motley Fool
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’
↗
December 21, 2023
It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."
Via
InvestorPlace
Should you consider NASDAQ:VRTX for quality investing?
↗
December 21, 2023
Reasonable Growth, Debt Levels, and a High ROIC Make VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) Appealing to Quality Investors.
Via
Chartmill
Is Vertex Pharmaceuticals Sitting on a Gold Mine?
↗
December 21, 2023
Vertex shares have climbed about 40% this year.
Via
The Motley Fool
CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief
↗
December 20, 2023
The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.
Via
InvestorPlace
Better Growth Stock: Archer Aviation or Prime Medicine?
↗
December 19, 2023
Which of these innovation-themed growth stocks is the better buy?
Via
The Motley Fool
Vertex to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
December 18, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
2 Stocks Profiting From Unstoppable Trends That Could Make You Rich
↗
December 18, 2023
It's important to choose companies involved in trends that have long-term potential.
Via
The Motley Fool
CRISPR Therapeutics Just Made History. So Why Did Its Stock Fall?
↗
December 16, 2023
The benefits from its first drug launch will trickle in slowly, at least at first.
Via
The Motley Fool
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip
↗
December 16, 2023
This biotech could have more winners on the way.
Via
The Motley Fool
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
